Development of the First Tractable Genetic System for Parvimonas micra, a Ubiquitous Pathobiont in Human Dysbiotic

Dustin L Higashi1, Sean McGuire2, Yasser M Abdelrahman1,3

  • 1Department of Restorative Dentistry, Oregon Health and Science University, Portland, Oregon, USA.

Microbiology Spectrum
|April 13, 2022
PubMed

Insights

Parvimonas micra, a bacterium linked to disease and cancer, is now genetically tractable. Researchers developed new methods to study its role in infections and tumor development.

Area of Science:

  • Microbiology
  • Genetics
  • Molecular Biology

Background:

  • Parvimonas micra is a common human gut bacterium.
  • It is frequently found in dysbiotic conditions and associated with various cancers.
  • Limited understanding of P. micra pathobiology is due to its genetic intractability.

Purpose of the Study:

  • To develop a tractable genetic system for Parvimonas micra.
  • To enable molecular genetic research into P. micra's role in disease and infection.

Main Methods:

  • Isolated P. micra strains from clinical specimens.
  • Screened isolates for natural competence.
  • Developed bioluminescence and riboswitch reporter systems.
  • Established mariner-based transposon sequencing (Tn-seq) for genetic screening.

Main Results:

  • All clinical P. micra isolates demonstrated natural competence.
  • Successfully engineered targeted chromosomal mutations.
  • Established a tunable gene expression system.
  • Generated Tn-seq libraries for forward genetic screening.

Conclusions:

  • Parvimonas micra is now a genetically tractable organism.
  • The developed genetic tools facilitate the study of P. micra in polymicrobial infections and tumorigenesis.
  • This research opens new avenues for investigating P. micra's role in human diseases.